According to the Report “Tissue Engineered - Skin Substitutes Market: By Type (Acellular, Cellular Allogeneic, Cellular Autologous, Others); By Application (Burn Injury, Diabetic/Vascular Ulcer and Others); & By Region - (2016-2022)” published by IndustryArc, the market to reach $2,874 million by 2022

Skin protects the body from exogenous substances and function as a barrier to fluid loss and injury. Tissue engineering plays a critical part in the production of skin equivalents for the treatment of chronic and particularly burn wounds. Tissue-engineered skin substitutes have recently become viable as an appropriate option to auto and allografts. On the other hand biologists, biochemists, and technical engineers are still struggling to produce complex skin substitutes that can readily be transplanted in large quantities. Most tissue-engineered skin is created by expanding skin cells in the laboratory (at a rate much greater than would be achieved on the patient) and using them to restore barrier function or to initiate wound healing. The global tissue-engineered skin substitutes market is forecast to reach revenue of $2,874m by 2022. 

Tissue engineered skin substitutes are cellular and acellular materials that aid in healing of damaged skin by releasing cytokines and growth factors at the wound site. Owing to the rise in skin diseases like vascular ulcers and having lowered immunity and blood flow, the Tissue Engineered - Skin Substitutes Market is poised to exhibit a healthy growth in coming years. Rapidly growing & urbanizing global population is set to impact the industry significantly. Tissue engineered - skin substitutes market is poised to witness significant growth owing to rise in healthcare infrastructure with technological advanced practice and higher spending in developing countries like China and India.

Skin substitutes differ in complexity and can be broadly classified into two types: synthetic, which are made up of acellular materials, and natural, which are made up of cellular materials. Rise in the prevalence of burn injuries and other skin diseases is one of the key factor that is driving the tissue engineered - skin substitutes market. Another major driving factor for tissue engineered - skin substitutes market is growing incidences of chronic and burn wounds coupled with rising geriatric population. North America is the dominant market for tissue engineered skin substitutes market followed by Europe and APAC region in terms of revenue. The market is more prevalent in the countries of the U.S., China, Germany and U.K. 

Sample Companies Profiled in this Report are:
  • Acelity L.P. Inc (U.S.)
  • Smith & Nephew PLC (U.K.)
  • Integra LifeSciences Holdings Corporation (U.S.)
  • Medtronic (Ireland)
  • BSN Medical GmbH (Germany) 
  • 10+

Companies are continuously investing into R&D and new product launches in order to increase their market share. These key players account for approximately 60% share of the total tissue engineered - skin substitutes market revenue. 

Browse Related Reports:

About IndustryARC:

IndustryARC is a research and consulting firm that publishes more than 500 reports annually in various industries, such as Agriculture, Automotive, Automation & Instrumentation, Chemicals and Materials, Energy and Power, Electronics, Food & Beverages, Information Technology, Life sciences & Healthcare.

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.

We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals. Contact us to find out how we can help you today.

Contact Us:

Mr. Venkateshwar Reddy
Business Development Manager 
Contact Sales: 1-614-588-8538 (Ext-101)
Connect with us on LinkedIn -